144 related articles for article (PubMed ID: 27494686)
21. Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis.
Wu B; Walker J; Spur B; Rodriguez A; Yin K
Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():55-64. PubMed ID: 25476955
[TBL] [Abstract][Full Text] [Related]
22. The Effect and Mechanism of Lipoxin A4 on Neutrophil Function in LPS-Induced Lung Injury.
Pan WH; Hu X; Chen B; Xu QC; Mei HX
Inflammation; 2022 Oct; 45(5):1950-1967. PubMed ID: 35438373
[TBL] [Abstract][Full Text] [Related]
23. The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.
Li G; Wu P; Xu Y; Yu Y; Sun L; Zhu L; Ye D
BMC Musculoskelet Disord; 2009 Jun; 10():57. PubMed ID: 19490628
[TBL] [Abstract][Full Text] [Related]
24. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes.
Andersson P; Serhan CN; Petasis NA; Palmblad J
Scand J Immunol; 2004 Sep; 60(3):249-56. PubMed ID: 15320881
[TBL] [Abstract][Full Text] [Related]
25. Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway.
Wu R; Zhou W; Chen S; Shi Y; Su L; Zhu M; Chen Q; Chen Q
Br J Pharmacol; 2014 Nov; 171(21):4927-40. PubMed ID: 24923883
[TBL] [Abstract][Full Text] [Related]
26. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.
Hu F; Liu XX; Wang X; Alashkar M; Zhang S; Xu JT; Zhong XL; He MW; Feng AP; Chen HX
J Dermatol Sci; 2015 Jun; 78(3):181-8. PubMed ID: 25847211
[TBL] [Abstract][Full Text] [Related]
27. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway.
Jiang X; Li Z; Jiang S; Tong X; Zou X; Wang W; Zhang Z; Wu L; Tian D
Int J Mol Med; 2016 Mar; 37(3):773-80. PubMed ID: 26865215
[TBL] [Abstract][Full Text] [Related]
28. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
Higgins G; Buchanan P; Perriere M; Al-Alawi M; Costello RW; Verriere V; McNally P; Harvey BJ; Urbach V
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):178-90. PubMed ID: 24588705
[TBL] [Abstract][Full Text] [Related]
29. The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
Kamigaki M; Hide I; Yanase Y; Shiraki H; Harada K; Tanaka Y; Seki T; Shirafuji T; Tanaka S; Hide M; Sakai N
Neurochem Int; 2016 Feb; 93():82-94. PubMed ID: 26802935
[TBL] [Abstract][Full Text] [Related]
30. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
31. Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins.
Cianci E; Recchiuti A; Trubiani O; Diomede F; Marchisio M; Miscia S; Colas RA; Dalli J; Serhan CN; Romano M
Stem Cells Transl Med; 2016 Jan; 5(1):20-32. PubMed ID: 26607175
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4.
Yu X; Wang Y; Lin J; Hu Y; Kawai T; Taubman MA; Han X
PLoS One; 2016; 11(11):e0165862. PubMed ID: 27812176
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic effect of Lipoxin A
Pádua TA; Torres ND; Candéa ALP; Costa MFS; Silva JD; Silva-Filho JL; Costa FTM; Rocco PRM; Souza MC; Henriques MG
J Leukoc Biol; 2018 Apr; 103(4):657-670. PubMed ID: 29345368
[TBL] [Abstract][Full Text] [Related]
34. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
35. The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response.
Djoumerska-Alexieva I; Pashova S; Vassilev T; Pashov A
Autoimmun Rev; 2013 Apr; 12(6):653-6. PubMed ID: 23201921
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-Phosphate Receptor Type 4 (S1P
Riese J; Gromann A; Lührs F; Kleinwort A; Schulze T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801658
[TBL] [Abstract][Full Text] [Related]
37. Lipoxin A4 attenuates LPS-induced mouse acute lung injury via Nrf2-mediated E-cadherin expression in airway epithelial cells.
Cheng X; He S; Yuan J; Miao S; Gao H; Zhang J; Li Y; Peng W; Wu P
Free Radic Biol Med; 2016 Apr; 93():52-66. PubMed ID: 26845617
[TBL] [Abstract][Full Text] [Related]
38. Lipoxin A4 Ameliorates Lipopolysaccharide-Induced A549 Cell Injury through Upregulation of N-myc Downstream-Regulated Gene-1.
Zhang JZ; Liu ZL; Zhang YX; Lin HJ; Zhang ZJ
Chin Med J (Engl); 2018 Jun; 131(11):1342-1348. PubMed ID: 29786049
[TBL] [Abstract][Full Text] [Related]
39. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.
Fang X; Abbott J; Cheng L; Colby JK; Lee JW; Levy BD; Matthay MA
J Immunol; 2015 Aug; 195(3):875-81. PubMed ID: 26116507
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats.
Karim MJ; Bhattacherjee P; Biswas S; Paterson CA
J Ocul Pharmacol Ther; 2009 Dec; 25(6):483-6. PubMed ID: 20021273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
